Sabra Healthcare REIT's (SBRA) Buy (B) Rating Reiterated at Weiss Ratings

Key Points

• Sabra Healthcare REIT's stock has been given a reiterated "buy" rating by Weiss Ratings, indicating strong analyst confidence in the company.
• Multiple analysts have recently adjusted their price targets for SBRA, with JMP Securities increasing the target from $20.00 to $22.00, reflecting a positive outlook on the stock.
• The company reported $0.38 EPS for the last quarter, exceeding expectations and showing a 7.4% increase in revenue year-over-year.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report)'s stock had its "buy (b)" rating restated by investment analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

SBRA has been the topic of a number of other reports. JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Scotiabank boosted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Cantor Fitzgerald began coverage on Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a "neutral" rating and a $20.00 price target on the stock. Truist Financial boosted their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research note on Tuesday, September 2nd. Finally, Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.71.

Sabra Healthcare REIT Trading Down 0.2%

Sabra Healthcare REIT stock opened at $17.98 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The business's 50-day simple moving average is $18.77 and its 200-day simple moving average is $18.16. The firm has a market capitalization of $4.31 billion, a PE ratio of 23.66, a PEG ratio of 1.21 and a beta of 0.85. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently added to or reduced their stakes in SBRA. Nuveen LLC acquired a new stake in Sabra Healthcare REIT during the first quarter valued at approximately $61,791,000. Engineers Gate Manager LP boosted its holdings in shares of Sabra Healthcare REIT by 3,190.3% in the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust's stock worth $58,626,000 after acquiring an additional 3,082,677 shares in the last quarter. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the 2nd quarter worth approximately $54,385,000. Balyasny Asset Management L.P. acquired a new position in shares of Sabra Healthcare REIT in the 2nd quarter worth approximately $49,955,000. Finally, Bank of Montreal Can boosted its holdings in shares of Sabra Healthcare REIT by 244.1% in the 2nd quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust's stock worth $47,501,000 after acquiring an additional 1,827,361 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.